[go: up one dir, main page]

MX2010003474A - Esterilizante quimico para control de poblacion de perros macho adultos, que comprende un gluconato mineral y un aminoacido. - Google Patents

Esterilizante quimico para control de poblacion de perros macho adultos, que comprende un gluconato mineral y un aminoacido.

Info

Publication number
MX2010003474A
MX2010003474A MX2010003474A MX2010003474A MX2010003474A MX 2010003474 A MX2010003474 A MX 2010003474A MX 2010003474 A MX2010003474 A MX 2010003474A MX 2010003474 A MX2010003474 A MX 2010003474A MX 2010003474 A MX2010003474 A MX 2010003474A
Authority
MX
Mexico
Prior art keywords
dog
amino acid
adult male
free
chemical sterilant
Prior art date
Application number
MX2010003474A
Other languages
English (en)
Inventor
Min Wang
Original Assignee
Fahim Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fahim Technology Inc filed Critical Fahim Technology Inc
Publication of MX2010003474A publication Critical patent/MX2010003474A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Feed For Specific Animals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composición química para utilizar en control de la población de perros macho, sexualmente maduros, callejeros. El esterilizante químico se inyecta de manera tal que la apariencia del perro y las características sexuales masculinas secundarias se conservan, de manera tal que el perro mantenga su posición en la jerarquía de los perros callejeros, mientras que no contribuyen al número de cachorros producidos. Una reducción en el número de perros callejeros, reduce el número de víctimas humanas de rabia adquirida por mordida de perro. Debido a que la apariencia y naturaleza del perro esterilizado sustancialmente no cambia, la composición química es aceptable para la comunidad humana en la que habita el perro.
MX2010003474A 2007-09-28 2008-09-26 Esterilizante quimico para control de poblacion de perros macho adultos, que comprende un gluconato mineral y un aminoacido. MX2010003474A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/863,758 US20090088471A1 (en) 2007-09-28 2007-09-28 Chemical sterilant for adult male dog population control with concomitant reduction in human dog-bite acquired rabies
PCT/US2008/011187 WO2009045337A1 (en) 2007-09-28 2008-09-26 Chemical sterilant for adult male dog population control, comprising a mineral gluconate and an amino acid

Publications (1)

Publication Number Publication Date
MX2010003474A true MX2010003474A (es) 2010-08-04

Family

ID=40089865

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003474A MX2010003474A (es) 2007-09-28 2008-09-26 Esterilizante quimico para control de poblacion de perros macho adultos, que comprende un gluconato mineral y un aminoacido.

Country Status (12)

Country Link
US (1) US20090088471A1 (es)
EP (1) EP2192897A1 (es)
CN (1) CN101888838A (es)
AR (1) AR068581A1 (es)
BR (1) BRPI0804518A2 (es)
CL (1) CL2008002909A1 (es)
CO (1) CO6270316A2 (es)
MX (1) MX2010003474A (es)
PA (1) PA8797601A1 (es)
PE (1) PE20091031A1 (es)
RU (1) RU2455000C2 (es)
WO (1) WO2009045337A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4588503A3 (en) 2011-01-03 2025-10-01 The Regents of the University of California High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury
JP2014533183A (ja) 2011-11-11 2014-12-11 ニューロイネイブリング テクノロジーズ インコーポレイテッド 運動神経、感覚、自律、性的、血管運動および認知機能の回復を可能にするための非侵襲性神経調節装置
HRP20211366T1 (hr) * 2012-08-23 2021-12-24 Senestech, Inc. Metoda kontrole veličine populacije nehumanih sisavaca
US20140271716A1 (en) 2013-03-15 2014-09-18 Ark Sciences, Inc. Intra-testicular Injection of Immunogens
EP2968940B1 (en) 2013-03-15 2021-04-07 The Regents Of The University Of California Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion
WO2015048563A2 (en) 2013-09-27 2015-04-02 The Regents Of The University Of California Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects
EP4473909A3 (en) 2017-02-17 2025-01-29 The University of British Columbia Apparatus and methods for maintaining physiological functions
US12434068B2 (en) 2017-05-23 2025-10-07 The Regents Of The University Of California Accessing spinal networks to address sexual dysfunction
EP3974021B1 (en) 2017-06-30 2023-06-14 ONWARD Medical N.V. A system for neuromodulation
US12357828B2 (en) 2017-12-05 2025-07-15 Ecole Polytechnique Federale De Lausanne (Epfl) System for planning and/or providing neuromodulation
EP3720338B1 (en) 2017-12-05 2025-09-24 Ecole Polytechnique Fédérale de Lausanne (EPFL) A system for planning and/or providing neuromodulation
CA3110463A1 (en) 2018-08-23 2020-02-27 The Regents Of The University Of California Non-invasive spinal cord stimulation for nerve root palsy, cauda equina syndrome, and restoration of upper extremity function
EP3653256B1 (en) 2018-11-13 2022-03-30 ONWARD Medical N.V. Control system for movement reconstruction and/or restoration for a patient
EP3695878B1 (en) 2019-02-12 2023-04-19 ONWARD Medical N.V. A system for neuromodulation
EP3827875B1 (en) 2019-11-27 2023-07-05 ONWARD Medical N.V. Neuromodulation system
EP3827871A1 (en) 2019-11-27 2021-06-02 ONWARD Medical B.V. Neuromodulation system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4339438A (en) * 1976-01-23 1982-07-13 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes
US4156427A (en) * 1976-01-23 1979-05-29 The Curators Of The University Of Missouri Injectable male animal sterilant for selectively controlling the function of testes
US4937234A (en) * 1988-08-10 1990-06-26 Fahim Mostafa S Minerals in bioavailable form
US5070080A (en) * 1988-08-10 1991-12-03 Fahim Mostafa S Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form
US5372822A (en) * 1994-03-07 1994-12-13 Fahim; Mostafa S. Chemical castration
US7276535B1 (en) * 2003-04-14 2007-10-02 Technology Transfer, Inc. Intratesticular injection of chemical sterilant
US7125385B1 (en) * 2003-04-14 2006-10-24 Technology Transfer, Inc. Instrument for determining intratesticular dose and method for determining a dose

Also Published As

Publication number Publication date
CL2008002909A1 (es) 2009-09-04
RU2010116777A (ru) 2011-11-10
CN101888838A (zh) 2010-11-17
PA8797601A1 (es) 2010-05-26
US20090088471A1 (en) 2009-04-02
EP2192897A1 (en) 2010-06-09
WO2009045337A1 (en) 2009-04-09
BRPI0804518A2 (pt) 2011-08-30
AR068581A1 (es) 2009-11-18
RU2455000C2 (ru) 2012-07-10
CO6270316A2 (es) 2011-04-20
PE20091031A1 (es) 2009-08-19

Similar Documents

Publication Publication Date Title
MX2010003474A (es) Esterilizante quimico para control de poblacion de perros macho adultos, que comprende un gluconato mineral y un aminoacido.
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
AU2001271545A1 (en) Promoting whole body health
WO2002002063A8 (en) Promoting whole body health
NZ709704A (en) Protein formulations and methods of making same
BG108443A (en) Substituted oxazoliidinones for combinational therapy
UA95105C2 (ru) Применение производного лактамида для снижения токсичности в препарате, который может соприкасаться с кожей или глазами человека или животного, производные лактамида и способы их получения
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
MY151018A (en) Use of nutritional compositions for preventing disorders
WO2010106457A3 (en) 3-oxa-7-azabicyclo[3.3.1]nonanes
MX2009004561A (es) Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
EP2091325A4 (en) TOPICAL AVERMECTIN FORMULATIONS AND METHODS FOR PREVENTING AND PROPHYLAXIS OF INCIDENTAL AND TREATMENT-RESISTANT HEADFLAD STRAINS
ECSP066608A (es) Suspensiones acuosas de ciclesonide para nebulización
WO2008105088A1 (ja) 脊髄損傷治療薬剤
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
MXPA05014184A (es) Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
IL194353A0 (en) Lysobactin amides
TW200602068A (en) Antidiarrheal agent for livestock and poultry
BRPI0515378A (pt) formulações dermalmente aplicáveis para tratamento de doenças de pele em animais
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
TW201920649A (zh) 用於有害生物之防治之氨氧化微生物
WO2007120665A3 (en) Formulation and method for a skin treatment for animals
CL2009000987A1 (es) Composición de alimentación que comprende peptidoglicano y nucleotidos; y su uso para la profilaxis y/o tratamiento de enfermedades infecciosas en animales.
WO2006053788A3 (en) Alterations in seborrheic keratoses and their applications

Legal Events

Date Code Title Description
FA Abandonment or withdrawal